Market Cap 57.63B
Revenue (ttm) 293.96B
Net Income (ttm) 1.51B
EPS (ttm) N/A
PE Ratio 20.24
Forward PE 18.98
Profit Margin 0.51%
Debt to Equity Ratio 6.66
Volume 970,800
Avg Vol 1,527,604
Day's Range N/A - N/A
Shares Out 193.82M
Stochastic %K 44%
Beta 0.57
Analysts Strong Sell
Price Target $331.79

Company Profile

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management...

Industry: Medical Distribution
Sector: Healthcare
Phone: 610 727 7000
Address:
1 West First Avenue, Conshohocken, United States
ZacksResearch
ZacksResearch Jul. 11 at 4:55 PM
$COR up 32.4% YTD — Can it keep the pace? 🚀 🔹 Strong U.S. Healthcare Solutions driving growth 🔹 Adjusted EPS projected to rise 14-16% in FY2025 🔹 Recent acquisition expands specialty capabilities Discover the full growth story here 👉 https://www.zacks.com/stock/news/2573188/heres-why-you-should-add-cencora-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2573188-body-1317&ADID=SYND_STOCKTWITS_TWEET_2_2573188_BODY_1317
0 · Reply
ZacksResearch
ZacksResearch Jul. 11 at 12:44 PM
$COR is riding a strong growth wave — but is it enough? GLP-1 and specialty drug sales are fueling gains, making it a compelling pick now. But margin pressure and tough competition still loom large. See if the reward outweighs the risk 👉 https://www.zacks.com/stock/news/2573188/heres-why-you-should-add-cencora-stock-to-your-portfolio-now?cid=sm-stocktwits-0-2573188-teaser-1289&ADID=SYND_STOCKTWITS_TWEET_0_2573188_TEASER_1289
0 · Reply
Rayyleeee
Rayyleeee Jul. 10 at 9:43 PM
$CRWV $COR next catalyst should be their official announcement of a large-scale contract with Google this or next quarter...
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine Jul. 3 at 8:07 PM
Cencora ($COR) expands receivables facility to $1.5B with enhanced accordion flexibility. While this boosts liquidity for pharma distribution ops, the debt-heavy balance sheet (7.76x D/E ratio) still looms large. Clever financial engineering or kicking the can? Market will decide. https://www.sec.gov/Archives/edgar/data/1140859/000110465925065769/tm2519648d1_8k.htm
0 · Reply
Estimize
Estimize Jul. 2 at 10:00 PM
Wall St is expecting 3.82 EPS for $COR Q3 [Reporting 07/30 BMO] http://www.estimize.com/intro/cor?chart=historical&metric_name=eps&utm_cont
0 · Reply
JarvisFlow
JarvisFlow Jun. 30 at 2:54 PM
Jefferies has adjusted their stance on Cencora ( $COR ), setting the rating to Hold with a target price of 275 → 300.
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Jun. 30 at 2:53 PM
$COR Jefferies Maintains Hold on Cencora, Raises Price Target to $300
0 · Reply
StockAnalyticsAI
StockAnalyticsAI Jun. 23 at 6:53 PM
$COR Deep Dive https://youtu.be/bslxGpFMPJs?si=HBEUX6fFQVSNkmBL
0 · Reply
PanicSeller8
PanicSeller8 Jun. 17 at 2:49 PM
$CAH $MCK $COR "Boring" space, but a good one to be in.
0 · Reply
harmongreg
harmongreg Jun. 15 at 3:44 PM
5 Trade Ideas for Monday: Antero, Cencora, CVS, J&J and Marathon Petroleum $AR $COR $CVS $JNJ $MPC https://dragonflycap.com/5-trade-ideas-for-monday-antero-cencora-cvs-jj-and-marathon-petroleum/
0 · Reply
Latest News on COR
Cencora Elects Lori J. Ryerkerk to Its Board of Directors

May 28, 2025, 7:30 AM EDT - 6 weeks ago

Cencora Elects Lori J. Ryerkerk to Its Board of Directors


Cencora, Inc. (COR) Q2 2025 Earnings Call Transcript

May 7, 2025, 10:55 AM EDT - 2 months ago

Cencora, Inc. (COR) Q2 2025 Earnings Call Transcript


Cencora Reports Fiscal 2025 Second Quarter Results

May 7, 2025, 6:30 AM EDT - 2 months ago

Cencora Reports Fiscal 2025 Second Quarter Results


3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

Apr 4, 2025, 3:42 PM EDT - 3 months ago

3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

CVS MCK PM


Cencora: Higher Potential Returns After Reduced Walgreens Stake

Feb 26, 2025, 11:00 AM EST - 4 months ago

Cencora: Higher Potential Returns After Reduced Walgreens Stake


Cencora (COR) Q1 2025 Earnings Call Transcript

Feb 5, 2025, 11:40 AM EST - 5 months ago

Cencora (COR) Q1 2025 Earnings Call Transcript


Cencora raises 2025 profit forecast on specialty drug demand

Feb 5, 2025, 7:23 AM EST - 5 months ago

Cencora raises 2025 profit forecast on specialty drug demand


Cencora Reports Fiscal 2025 First Quarter Results

Feb 5, 2025, 6:30 AM EST - 5 months ago

Cencora Reports Fiscal 2025 First Quarter Results


Cencora raises annual profit forecast

Jan 2, 2025, 4:23 PM EST - 6 months ago

Cencora raises annual profit forecast


Cencora Completes Acquisition of Retina Consultants of America

Jan 2, 2025, 4:15 PM EST - 6 months ago

Cencora Completes Acquisition of Retina Consultants of America


Cencora Closes $1.8 Billion Senior Notes Offering

Dec 9, 2024, 4:15 PM EST - 7 months ago

Cencora Closes $1.8 Billion Senior Notes Offering


Cencora: Competitive Advantages Defined

Dec 5, 2024, 10:26 AM EST - 7 months ago

Cencora: Competitive Advantages Defined


Cencora to Host Inaugural Product Showcase

Nov 26, 2024, 8:30 AM EST - 8 months ago

Cencora to Host Inaugural Product Showcase


Cencora, Inc. (COR) Q4 2024 Earnings Call Transcript

Nov 6, 2024, 10:56 AM EST - 8 months ago

Cencora, Inc. (COR) Q4 2024 Earnings Call Transcript


Cencora to buy Retina Consultants of America for $4.6 bln

Nov 6, 2024, 6:54 AM EST - 8 months ago

Cencora to buy Retina Consultants of America for $4.6 bln


Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results

Nov 6, 2024, 6:35 AM EST - 8 months ago

Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results


Dividend Aristocrats Of The Future - Part 3

Nov 1, 2024, 4:42 PM EDT - 9 months ago

Dividend Aristocrats Of The Future - Part 3

AIZ COST CSX DUK K RSG SRE


Cencora Elects Frank Clyburn to Its Board of Directors

Aug 15, 2024, 7:30 AM EDT - 11 months ago

Cencora Elects Frank Clyburn to Its Board of Directors


Walgreens further reduces stake in Cencora

Aug 1, 2024, 6:20 PM EDT - 1 year ago

Walgreens further reduces stake in Cencora

WBA


Cencora says additional data stolen in February cyberattack

Jul 31, 2024, 6:14 PM EDT - 1 year ago

Cencora says additional data stolen in February cyberattack


Cencora, Inc. (COR) Q3 2024 Earnings Call Transcript

Jul 31, 2024, 11:12 AM EDT - 1 year ago

Cencora, Inc. (COR) Q3 2024 Earnings Call Transcript


Cencora Reports Fiscal 2024 Third Quarter Results

Jul 31, 2024, 6:30 AM EDT - 1 year ago

Cencora Reports Fiscal 2024 Third Quarter Results


Cencora: Long-Term Compounder With Mouth-Watering Economics

Jun 24, 2024, 12:20 PM EDT - 1 year ago

Cencora: Long-Term Compounder With Mouth-Watering Economics


ZacksResearch
ZacksResearch Jul. 11 at 4:55 PM
$COR up 32.4% YTD — Can it keep the pace? 🚀 🔹 Strong U.S. Healthcare Solutions driving growth 🔹 Adjusted EPS projected to rise 14-16% in FY2025 🔹 Recent acquisition expands specialty capabilities Discover the full growth story here 👉 https://www.zacks.com/stock/news/2573188/heres-why-you-should-add-cencora-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2573188-body-1317&ADID=SYND_STOCKTWITS_TWEET_2_2573188_BODY_1317
0 · Reply
ZacksResearch
ZacksResearch Jul. 11 at 12:44 PM
$COR is riding a strong growth wave — but is it enough? GLP-1 and specialty drug sales are fueling gains, making it a compelling pick now. But margin pressure and tough competition still loom large. See if the reward outweighs the risk 👉 https://www.zacks.com/stock/news/2573188/heres-why-you-should-add-cencora-stock-to-your-portfolio-now?cid=sm-stocktwits-0-2573188-teaser-1289&ADID=SYND_STOCKTWITS_TWEET_0_2573188_TEASER_1289
0 · Reply
Rayyleeee
Rayyleeee Jul. 10 at 9:43 PM
$CRWV $COR next catalyst should be their official announcement of a large-scale contract with Google this or next quarter...
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine Jul. 3 at 8:07 PM
Cencora ($COR) expands receivables facility to $1.5B with enhanced accordion flexibility. While this boosts liquidity for pharma distribution ops, the debt-heavy balance sheet (7.76x D/E ratio) still looms large. Clever financial engineering or kicking the can? Market will decide. https://www.sec.gov/Archives/edgar/data/1140859/000110465925065769/tm2519648d1_8k.htm
0 · Reply
Estimize
Estimize Jul. 2 at 10:00 PM
Wall St is expecting 3.82 EPS for $COR Q3 [Reporting 07/30 BMO] http://www.estimize.com/intro/cor?chart=historical&metric_name=eps&utm_cont
0 · Reply
JarvisFlow
JarvisFlow Jun. 30 at 2:54 PM
Jefferies has adjusted their stance on Cencora ( $COR ), setting the rating to Hold with a target price of 275 → 300.
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Jun. 30 at 2:53 PM
$COR Jefferies Maintains Hold on Cencora, Raises Price Target to $300
0 · Reply
StockAnalyticsAI
StockAnalyticsAI Jun. 23 at 6:53 PM
$COR Deep Dive https://youtu.be/bslxGpFMPJs?si=HBEUX6fFQVSNkmBL
0 · Reply
PanicSeller8
PanicSeller8 Jun. 17 at 2:49 PM
$CAH $MCK $COR "Boring" space, but a good one to be in.
0 · Reply
harmongreg
harmongreg Jun. 15 at 3:44 PM
5 Trade Ideas for Monday: Antero, Cencora, CVS, J&J and Marathon Petroleum $AR $COR $CVS $JNJ $MPC https://dragonflycap.com/5-trade-ideas-for-monday-antero-cencora-cvs-jj-and-marathon-petroleum/
0 · Reply
QuiverQuant
QuiverQuant Jun. 6 at 2:57 PM
New Analyst Forecast: $COR Given 'Overweight' Rating Read more on $COR: https://www.quiverquant.com/news/New+Analyst+Forecast%3A+%24COR+Given+%27Overweight%27+Rating
0 · Reply
erevnon
erevnon Jun. 3 at 2:43 PM
Wells Fargo upgrades Cencora $COR from Equal-Weight to Overweight and raises the price target from $274 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
JarvisFlow
JarvisFlow Jun. 3 at 1:00 PM
Wells Fargo updates rating for Cencora ( $COR ) to Overweight, target set at 274 → 337.
0 · Reply
ZacksResearch
ZacksResearch May. 30 at 2:16 PM
$COR up 29.4% YTD—what's driving this rally? 🚀 🌟 Strong U.S. Healthcare Solutions performance 💊 Specialty & GLP-1 medications boost growth 📈 Adjusted EPS projected to rise 14-16% in fiscal 2025 See why Cencora is a Zacks Rank #2 Buy 👉 https://www.zacks.com/commentary/2479450/heres-why-you-should-add-cencora-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2479450-body&ADID=SYND_STOCKTWITS_TWEET_2_2479450_BODY
0 · Reply
ZacksResearch
ZacksResearch May. 30 at 12:54 PM
$COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe. Read the full story here: https://www.zacks.com/stock/news/2479450/heres-why-you-should-add-cencora-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2479450-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2479450_TEASER
0 · Reply
TradeInYourJob
TradeInYourJob May. 30 at 12:33 AM
$COR Sell Signal on the weekly timeframe CCI and negative divergence in the onbalance volume.
0 · Reply
EPSMomentumStocks
EPSMomentumStocks May. 21 at 11:31 AM
Is $COR maintaining its trajectory within the projected Post-Earnings Announcement Drift (PEAD) cone? Monitoring whether the stock's price action remains within this forecasted range helps assess the accuracy of the earnings-based predictive model and potential deviations in momentum. #stocks #trading #investing
0 · Reply
NxtBgThng
NxtBgThng May. 17 at 2:19 AM
$OTLK started buying $COR when Outlook hired them to market lytenava as buyout rumors were swirling. Has worked out well.
0 · Reply
CLiZzY
CLiZzY May. 15 at 2:53 PM
$COR looks pretty solid
0 · Reply
IN0V8
IN0V8 May. 12 at 4:50 PM
$COR JP Morgan raises target price to $326 from $301
0 · Reply
DonCorleone77
DonCorleone77 May. 12 at 2:58 PM
$UNH $CI $CAH $COR $MCK Trump says will 'cut out middlemen' to reduce drug prices President Donald Trump made the comment while speaking from the White House.
0 · Reply
1986iamwallstreet
1986iamwallstreet May. 12 at 2:26 PM
$COR bleeding 🩸
0 · Reply